ENDRA Life Sciences (NDRA) Capital Expenditures (2018 - 2025)
ENDRA Life Sciences (NDRA) posted quarterly Capital Expenditures of $17280.0 for Q1 2025, down 36.0% year-over-year from $27000.0 in Q1 2024, and up 257.09% quarter-over-quarter from -$11000.0 in Q2 2024.
ENDRA Life Sciences (NDRA) Capital Expenditures (2018 - 2025) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Capital Expenditures for 8 consecutive years, with $17280.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Capital Expenditures fell 36.0% year-over-year to $17280.0; the TTM figure through Dec 2025 stood at $17280.0 (up 8.0% YoY), while the FY2025 annual figure was $17280.0, up 8.0% from the prior year.
- Capital Expenditures climbed to $17280.0 in Q1 2025 per NDRA's latest filing, from -$11000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $89353.0 in Q1 2022 and bottomed at -$11000.0 in Q2 2024.
- Historically, Capital Expenditures has averaged $31474.1 across 5 years, with a median of $27000.0 in 2023.
- Annual changes were most pronounced in 2021 — Capital Expenditures soared 101.34% — and 2023, when it sank 82.15%.
- ENDRA Life Sciences' Capital Expenditures stood at $45000.0 in 2021, then decreased by 14.3% to $38563.0 in 2022, then tumbled by 82.15% to $6884.0 in 2023, then tumbled by 259.79% to -$11000.0 in 2024, then soared by 257.09% to $17280.0 in 2025.
- Business Quant data shows NDRA's Capital Expenditures at $17280.0 in Q1 2025, -$11000.0 in Q2 2024, and $27000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 450.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 269.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 76.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 198.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.65 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 40.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.79 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 131.60 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 17,280.00 |
| Mar 31, 2025 | 17,280.00 |
| Jun 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 6,884.00 |
| Dec 31, 2023 | 6,884.00 |
| Mar 31, 2023 | 27,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2022 | 38,563.00 |
| Dec 31, 2022 | 38,563.00 |
| Sep 30, 2022 | 14,861.00 |
| Sep 30, 2022 | 14,861.00 |
| Jun 30, 2022 | 59,800.00 |
| Jun 30, 2022 | 59,800.00 |
| Mar 31, 2022 | 89,353.00 |
| Mar 31, 2022 | 89,353.00 |
| Mar 31, 2021 | 45,000.00 |
| Mar 31, 2021 | 45,000.00 |